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Evidence that the bulge region  
is a site of relative immune privilege  
in human hair follicles
Immune privilege (IP) 
describes a group of 
mechanisms that sup-
press local immune 
responses in a defined 
tissue site. Using 
immunohistochemis-
try, quantitative anal-
ysis and skin organ 
culture Meyer et al. show that the human hair follicle bulge 
also displays features of IP, i.e. downregulation of major histo-
compatibility complex (MHC) I, MHC II and β2-microglobulin 
immunoreactivity, and upregulation of immunosuppressants 
(e.g. transforming growth factor-β2, α-melanocyte stimulating 
hormone, indoleamine-2,3-dioxygenase, macrophage migra-
tion inhibitory factor), CD200 and HLA-E. The role of bulge IP 
appears to be to protect the epithelial hair follicle stem cells in 
this area from immune attack. Therefore, loss of bulge IP may 
play a role in pathogenesis of primary cicatricial alopecia. Br J 
Dermatol 2008; 159:1077–85.
Hyperglycaemic conditions decrease 
cultured keratinocyte mobility: 
implications for impaired wound 
healing in patients with diabetes
Lan et al. have studied the effects of high glucose on keratino-
cyte proliferation and migration, as alterations in these process-
es may explain why poor wound healing is common in patients 
with diabetes. Keratinocytes were cultivated in normal and high 
glucose conditions. Their viability and mobility were evaluated. 
The mRNA expressions and activities of matrix metalloprotei-
nase (MMP)-2 and MMP-9 were determined. The mRNA of 
their respective physiological inhibitors, tissue inhibitor of MMP 
(TIMP)-1 and TIMP-2, was also evaluated. Immunofluorescent 
staining and Western blotting were used to examine the expres-
sion of phosphorylated focal adhesion kinase (pp125FAK). The 
impacts of high glucose on keratinocyte proliferation were 
assessed by 5-bromo-2’-deoxyuridine incorporation assay. 
High glucose treatment did not affect keratinocyte viability up 
to 3 days. In contrast, the mobility of keratinocytes, the activi-
ties and gene expressions of MMP-2 and MMP-9, the expres-
sion of pp125FAK, and the cell proliferation after 5 days were 
significantly downregulated after hyperglycaemic treatments 
while the mRNA expression of TIMP-1 increased. Keratinocytes 
demonstrated reduced migration and decreased proliferation 
capacities under hyperglycaemic conditions. Br J Dermatol 
2008; 159:1103–15.
The influence of antimalarial treatment 
on IL-1β, IL-6 and TNF-α mRNA 
expression on UVB-irradiated skin  
in systemic lupus erythematosus
Little is known about the cutaneous mechanisms of the anti-
lupus effects of antimalarials. The influence was studied of 3 
months of monotherapy with chloroquine on the skin mRNA 
expression of interleukin (IL)-1β, IL-6 and tumour necrosis 
factor (TNF)-α in nonirradiated and locally ultraviolet (UV) 
B-irradiated nondiseased skin of patients with systemic lupus 
erythematosus (SLE). There were no significant differences in 
the cytokine mRNA expression levels in the unirradiated sites 
before and after 3 months of chloroquine administration. In 
the irradiated sites, the mRNA expression levels of all three 
cytokines were significantly higher than in the unirradiated 
group, approximately 24 h after irradiation, before chloro-
quine treatment. Significantly lower expressions of IL-1β, IL-6 
and TNF-α mRNAs were noted in irradiated skin samples after 
3 months of chloroquine treatment. These results demonstrate 
the local inhibitory effects of chloroquine on UVB-induced 
upregulation in the mRNA expression of proinflammatory 
cytokines in irradiated skin of patients with SLE, and provide 
further insight into the apparent immunomodulatory, anti-
inflammatory and photoprotective properties of chloroquine. 
Br J Dermatol 2008; 159:1142–8.
Human herpesvirus 7 detection by 
quantitative real time polymerase  
chain reaction in primary cutaneous 
T-cell lymphomas and healthy subjects:  
lack of a pathogenic role
Viral infection has been sug-
gested for superantigenic 
activation of T lymphocytes 
in the pathogenesis of pri-
mary cutaneous T-cell lym-
phoma (CTCL). Human her-
pesvirus 7 (HHV7), a CD4+ 
T-lymphotropic herpesvirus, 
could constitute a potential pathogenic cofactor. HHV7 DNA 
expression was investigated in patients with CTCL and healthy 
skin donors (HD) by quantitative real time polymerase chain 
reaction to evaluate its potential pathogenic role. Twenty-
seven of 84 (32%) HD were positive for HHV7 DNA. As 
to CTCL, HHV7 DNA was positive in 23% of patients with 
Sézary syndrome, 43% with CD30+ large-cell lymphoma 
and 25% with lymphomatoid papulosis, while it was negative 
in all of 71 with mycosis fungoides. These results exclude a 
pathogenic role of HHV7 in CTCL, suggesting the possibility 
of skin as a latency site. Br J Dermatol 2008; 159:1149–55.
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